Dr Girish Achliya, Head-R&D, Gowrie Research
Vadodara Pharma Summit 2024 | 25th October 2024 | Vadodara
Author
Dr Vasanthakumar Ramu, VP & Head R&D – Peptides & Complex APIs, Alembic Pharma
Vadodara Pharma Summit 2024 | 25th October 2024 | Vadodara
Stinita Dsouza, Application Specialist, Equitron Medica
Vadodara Pharma Summit 2024 | 25th October 2024 | Vadodara
Prabhat Balyan, Manager – Business Development, Ami Polymer
Vadodara Pharma Summit 2024 | 25th October 2024 | Vadodara
Dhairy Sharma, Sr Executive – Business Development, Cilicant
Vadodara Pharma Summit 2024 | 25th October 2024 | Vadodara
Panel Discussion on ‘Next growth frontiers for India Pharma Inc’
Vadodara Pharma Summit 2024 | 25th October 2024 | Vadodara
Ichnos Glenmark Innovation to present phase 1 study data on Trispecific Antibody ISB 2001 at ASH…
Early results show promising response rates and safety profile for ISB 2001 in relapsed/refractory multiple myeloma patients
Venus Remedies gains Malaysian PIC/S GMP approval for pre-filled syringe facility
The accreditation facilitates quicker approvals across the ASEAN region and opens new global business opportunities for Venus…
CPHI India reports surge in exhibitor numbers as modernisation and supply chain diversity drive new…
India tops CPHI survey growth ranking for 2025 – the third consecutive year it is identified as the fastest-growing region
Hims & Hers Health to introduce generic Liraglutide in 2025 amid growing demand for weight-loss…
The move taps into surging demand for appetite-suppressing GLP-1 agonists, set against ongoing shortages of newer weight-loss…